Drug labels: Understanding safety information
Decisions about which medicines to prescribe our patients are based on many factors, safety being one of the most important. A medication’s safety information can be found in several sections of the drug label or package insert. This webinar will help participants better understand the information on FDA-approved drug labels, particularly in the post-approval experience section. Presenters will share findings from a 2019 survey of AVMA and NAVTA members on how drug labels are used and understood. They'll also explain how the findings can help improve the way a product’s safety information is conveyed. Come away knowing how to make more informed decisions about medication and product safety.
Participants can expect to learn about:
- Information on an FDA product label, including the post-approval experience section
- Findings from a national survey examining how veterinarians, veterinary technicians, and pet owners understand and use information on a product label
- How drug safety information is collected and shared, and how veterinarians can play a role in enhancing product labels by participating in adverse event reporting
ABOUT THE PRESENTERS:
 | Dr. Rachel Cumberbatch Dr. Rachel Cumberbatch serves as vice president for regulatory and international affairs at the Animal Health Institute, a nonprofit association representing manufacturers of animal health products. Previously, she was in clinical veterinary practice and served as a science fellow at the U.S. Environmental Protection Agency and the U.S. Senate. She earned her DVM from Purdue University. |
|---|
 | Julie Andrews Julie Andrews has more than 30 years' experience in animal health market research, having managed hundreds of research studies throughout her career. Her experience includes gathering data and insights on pricing, product development, brand performance, segmentation, and satisfaction for both national and global projects representing over 30 countries. She also conducts in-depth interviews with producers, nutritionists, and veterinarians representing all aspects of food animal production and companion animal care. As a senior vice president with Kynetec, she is responsible for North American animal health customer insights research projects. She earned her bachelor's degree in agricultural economics from the University of Missouri-Columbia and an MBA from University of Missouri-St. Louis. |
|---|
 | Dr. Tim Frana, MS, MPH, PhD, Diplomate, ACVPM, ACVM Dr. Tim Frana earned his DVM from Iowa State University and practiced companion animal and emergency medicine in Nevada and Arizona for 14 years. During this time, he completed a master’s degree in environmental resources from Arizona State University and a master’s degree in public health from University of Arizona. He returned to Iowa State University in 1999 as adjunct faculty while completing a PhD in veterinary microbiology. In 2002, he began working at the USDA Center for Veterinary Biologics, focusing on epidemiology and pharmacovigilance. In 2008, he became associate professor and head of bacteriology in the veterinary diagnostic laboratory at Iowa State University. In 2015, he joined Boehringer Ingelheim Animal Health, as associate director of global pharmacovigilance. |
|---|
 | Dr. Steven Nederveld Dr. Steven Nederveld earned his DVM from Michigan State University in 1997 and started his veterinary career in a mixed animal practice. He then worked as a field veterinarian for the Michigan Department of Agriculture’s animal industry division for nearly eight years. He moved to the pharmaceutical industry, serving as a clinical veterinarian in comparative medicine for Pfizer and Zoetis. In these roles he provided clinical care and surgical support of laboratory animals, monitored animal health surveillance and preventive medicine programs, and supported study planning and execution. As associate director of global pharmacovigilance, regulatory affairs at Zoetis, he leads the U.S. global pharmacovigilance medical and technical support team. |
|---|